Free News Reader

Medical AI Company Medow Health Seeks Investment

Free News Reader  ·  September 15, 2026

AI-generated context summary requested by a Free News Reader user. Sourced via Gemini from publicly available information — no paywalled content was accessed.

You hit a paywall. Here’s the context on this topic based on publicly available information. We did not access any paywalled content. View original article.

Medical AI Company Medow Health Seeks Investment

  • Sydney-based Medow Health AI, founded in 2023, recently secured A$3.5 million (approximately $2.5 million USD) in a seed funding round.
  • The company, co-founded by Joel and Josh Freiberg, aims to launch an AI-powered front desk product designed to automate bookings and inbound calls for specialist clinics.

Full Summary — powered by AI

Medow Health AI, a Sydney-based company established in 2023, is actively seeking investment to advance its artificial intelligence solutions for the medical sector. The company successfully raised A$3.5 million (approximately $2.5 million USD) in a seed funding round as of September 15, 2026. This investment is intended to support the rollout of an AI-powered front desk product specifically designed for specialist clinics.

The new product aims to streamline administrative tasks by managing inbound calls, handling bookings, and relaying patient messages to clinical staff. Medow Health AI’s offerings also include ambient AI that listens to consultations and generates various documents, such as GP letters, referral letters, and patient-facing communications, within seconds. The company emphasizes that its AI is specialty-specific, catering to over 50 medical specialties and integrating with existing practice management systems like Genie and Gentu to synchronize appointments and upload finalized notes.

Medow Health AI’s co-founders, Joel and Josh Freiberg, were inspired to create the company based on their personal experiences within the healthcare system, aiming to reduce the administrative burden on clinicians. The company previously secured an additional $3 million in funding as of November 2025, with continued support from specialist doctors who also invested in an earlier round. This follow-on funding was intended to accelerate global expansion and launch new products. The company reported significant growth, with a 300% increase in revenue and processing over 100,000 specialist consultations monthly as of November 2025.

The broader Australian healthcare landscape is increasingly adopting AI to enhance efficiency, with other companies like Heidi Health and Lyrebird Health also offering AI-powered medical scribe solutions that automate clinical documentation. These AI tools are designed to reduce administrative time, allowing medical professionals to focus more on patient care.